According to the New York Times, on December 10, 2012 the biotechnology giant, Amgen, said it was acquiring deCODE Genetics, a gene-hunting business known for its “headline grabbing discoveries linking genetic variations to disease. DeCODE, a privately held company in Iceland has studied the local population to identify genetic variations linked to schizophrenia, cancer and numerous other diseases.” Dr.
Uncategorized
DeCODE-ing TMD
